| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel
1 company
Todd Christopher Longsworth last filed a Form 4 in March 2022, as General Counsel at NVCR. From July 2017 to March 2022, the filings on record show 0 open-market purchases and 17 sales. Todd Christopher Longsworth's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Todd Christopher Longsworth a below-average insider score of 26/100, based on 3 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -8.2%.
At the last filing, the largest reported position was 62,462 shares of NVCR. The NVCR filings lean toward selling, a net 335,915 shares.
Shares as reported in the last Form 4 for each company; the most recent is from March 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2019 | NVCR Novocure Ltd | General Counsel | Sale+OE | 2,368 | $53.68 | $127,114.24 | -6.0% | |
| Feb 25, 2019 | NVCR Novocure Ltd | General Counsel | Sale+OE | 9,325 | $53.63 | $500,081.10 | -21.7% | |
| Jan 25, 2019 | NVCR Novocure Ltd | General Counsel | Sale+OE | 26,874 | $49.03 | $1,317,731.10 | -55.8% | |
| Jan 16, 2019 | NVCR Novocure Ltd | General Counsel | Sale+OE | 15,000 | $45.15 | $677,250.00 | -41.3% | |
| Jan 9, 2019 | NVCR Novocure Ltd | General Counsel | Sale+OE | 15,000 | $40.15 | $602,250.00 | -41.3% | |
| Feb 23, 2018 | NVCR Novocure Ltd | General Counsel | Sale+OE | 6,591 | $19.83 | $130,686.35 | -24.7% | |
| Jan 29, 2018 | NVCR Novocure Ltd | General Counsel | Sale+OE | 11,630 | $24.00 | $279,120.00 | -69.9% |